RAYNER
Business purpose.
La distribution de produits, principalement des lentilles Intraoculaires et des injecteurs, fournis et fabriqués par sa société mère ; la distribution d'une gamme de produits pharmaceutiques fabriquée par sa société mère et certains produits fabriqués par des tiers avec le consentement et l'approbation de sa société mère.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- 10 to 19 employees
- Created
- 2 Nov 2021
- Share capital
- 10,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 4
Directors
- DAVID GEOFFREY ALLAN 62 years old, 08/1964 Directeur general
- JAMES ANDREW CRUTCHLOW 47 years old, 08/1979 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- CLUNY via DAVID GEOFFREY ALLAN
Other companies at the same address
2 other company head offices are registered at this address.
Establishments
-
90521097700013 59000 LILLE
-
90521097700021 59700 MARCQ-EN-BARŒUL
-
90521097700039 59700 MARCQ-EN-BARŒUL
Financial strength
Financial score
39 / 100 D
Confidence: high · computed on the financial year ended 31 Dec 2025
- Equity to assets (-82.2 %)
- 0.0 out of 30
- EBITDA margin (8.6 %)
- 13.9 out of 25
- Liquidity (36.9 %)
- 0.5 out of 20
- Debt (0.0 %)
- 15.0 out of 15
- Revenue trend (39.9 %)
- 10.0 out of 10
formula fin-1.0
Legal score
90 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.0 years)
- 10.1 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 3,084,582 € | +39.9 % | 264,596 € | 199,664 € |
| 31 Dec 2024 | 2,204,110 € | +208.3 % | 42,485 € | -79,152 € |
| 31 Dec 2023 | 715,032 € | first year on record | -1,463,072 € | -1,470,042 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 12 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260131, annonce n 12052 · Proof of publication (PDF)
-
Filing of accounts 29 Jul 2025
- Court :
- Greffe du Tribunal des Activités Economiques de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250143, annonce n 30685 · Proof of publication (PDF)
-
Filing of accounts 29 Nov 2024
- Court :
- Greffe du Tribunal de Commerce de lille métropole
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240231, annonce n 2425 · Proof of publication (PDF)
-
Registration 29 Aug 2024
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Filing :
- immatriculation suite à transfert de son siège social hors ressort.
BODACC A n 20240167, annonce n 1160 · Proof of publication (PDF)
-
Filing of accounts 26 Mar 2024
- Court :
- Greffe du Tribunal de Commerce de lille métropole
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20240060, annonce n 3218 · Proof of publication (PDF)
-
Amendment 13 Jun 2023
- Court :
- Greffe du Tribunal de Commerce de Lille Métropole
- Amendment :
- modification survenue sur l'administration
BODACC B n 20230112, annonce n 2611 · Proof of publication (PDF)
-
Amendment 11 Sep 2022
- Court :
- Greffe du Tribunal de Commerce de Lille Métropole
- Amendment :
- modification survenue sur l'adresse du siège, l'adresse de l'établissement et la date de début d'activité
BODACC B n 20220176, annonce n 879 · Proof of publication (PDF)
-
Amendment 22 Mar 2022
- Court :
- Greffe du Tribunal de Commerce de Lille Métropole
- Amendment :
- modification survenue sur la dénomination, l'adresse du siège, l'adresse de l'établissement et la date de début d'activité
BODACC B n 20220057, annonce n 1800 · Proof of publication (PDF)
-
Incorporation 25 Nov 2021
- Court :
- Greffe du Tribunal de Commerce de Lille Métropole
BODACC A n 20210229, annonce n 1206 · Proof of publication (PDF)
Filings and accounts
- Formality 17 Apr 2024
Change history
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address 395 rue du General de Gaulle 59700 Marcq-en-Baroeul → 393 rue du General de Gaulle 59700 Marcq-en-Baroeul 3 Oct 2026
- registered_address (empty) → 395 rue du General de Gaulle 59700 Marcq-en-Baroeul 1 Oct 2026
- capital (empty) → 10000.00 1 Oct 2026
Frequently asked questions about RAYNER
- What is the SIREN number of RAYNER?
- The SIREN number of RAYNER is 905210977. Its intra-community VAT number is FR88905210977.
- Where is the head office of RAYNER?
- Head office address: 13 RUE TRANSVERSALE, 92230 GENNEVILLIERS.
- When was RAYNER founded?
- RAYNER was founded on 2 Nov 2021.
- What does RAYNER do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs RAYNER?
- The officers listed in the register are DAVID GEOFFREY ALLAN (Directeur general), JAMES ANDREW CRUTCHLOW (President de SAS).
- What is the revenue of RAYNER?
- The latest published revenue is 3,084,582 €, for the 2025 financial year.
- How many employees does RAYNER have?
- The declared headcount is 10 to 19 employees. Insee data for 2024.
- Is RAYNER subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.